首页> 外文期刊>Oncology letters >Mutation analysis of key genes in RAS/RAF and PI3K/PTEN pathways in Chinese patients with hepatocellular carcinoma
【24h】

Mutation analysis of key genes in RAS/RAF and PI3K/PTEN pathways in Chinese patients with hepatocellular carcinoma

机译:中国肝细胞癌患者RAS / RAF和PI3K / PTEN途径关键基因的突变分析

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The RAS/RAF and PI3K/PTEN signaling pathways play central roles in hepatocarcinogenesis. KRAS, NRAS, HRAS, BRAF, PIK3CA, PIK3R1 and PTEN are key cancer-related genes in the RAS/RAF and PI3K/PTEN signaling pathways. Genetic alterations in these genes often lead to the dysregulation of the two cascades. Little is known regarding the frequency of hotspot mutations in these critical components among Chinese patients with hepatocellular carcinoma (HCC). In the current study, 57 somatic hotspot mutations in 36 HCCs samples collected from Chinese patients using direct DNA sequencing method were examined. Two cases of KRAS somatic mutations (KRAS codon 61; Gln to His) were identified among 36 HCCs (5.6%). However, no mutations were found in the NRAS, HRAS, BRAF, PIK3CA, PIK3R1 and PTEN genes. These findings indicated that point mutations in the KRAS gene, but not mutations in NRAS, HRAS, BRAF, PIK3CA, PIK3R1 and PTEN genes, at a somatic level contribute to the abnormal activation of the RAS/RAF and PI3K/PTEN pathways in HCC.
机译:RAS / RAF和PI3K / PTEN信号通路在肝癌发生中起关键作用。 KRAS,NRAS,HRAS,BRAF,PIK3CA,PIK3R1和PTEN是RAS / RAF和PI3K / PTEN信号通路中与癌症相关的关键基因。这些基因的遗传改变通常导致两个级联的失调。在中国肝细胞癌(HCC)患者中,这些关键部位的热点突变发生频率知之甚少。在本研究中,使用直接DNA测序方法检查了从中国患者收集的36例肝癌样本中的57个体细胞热点突变。在36例HCC中,发现了2例KRAS体细胞突变(KRAS密码子61; Gln为His)(5.6%)。但是,在NRAS,HRAS,BRAF,PIK3CA,PIK3R1和PTEN基因中未发现突变。这些发现表明,在体细胞水平上,KRAS基因中的点突变,而不是NRAS,HRAS,BRAF,PIK3CA,PIK3R1和PTEN基因中的点突变,导致了HCC中RAS / RAF和PI3K / PTEN途径的异常激活。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号